Cetuximab: Uses, Interactions, Mechanism of Action | DrugBank Online
SMPDB
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. - Abstract - Europe PMC
MALDI-MSI of Immunotherapy: Mapping the EGFR-Targeting Antibody Cetuximab in 3D Colon-Cancer Cell Cultures | Analytical Chemistry
Antibodies | Free Full-Text | Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability
Structure of Cetuximab | Download Scientific Diagram
Enhancing bacterial production of a recombinant cetuximab-Fab by partial humanization and its utility for drug conjugation - ScienceDirect
Cancers | Free Full-Text | Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer
From combinatorial peptide selection to drug prototype (II): Targeting the epidermal growth factor receptor pathway | PNAS
Frontiers | Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors
A: Amino Acid Sequence of Cetuximab, heavy chain chain (Source:... | Download Scientific Diagram
Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment
Cetuximab–Polymersome–Mertansine Nanodrug for Potent and Targeted Therapy of EGFR-Positive Cancers | Biomacromolecules
Application of nano-surface and molecular-orientation limited proteolysis to LC–MS bioanalysis of cetuximab | Bioanalysis
Cancers | Free Full-Text | Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal Cancer
Structure of cetuximab showing glycosylation sites. Cetuximab is a... | Download Scientific Diagram
Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment
Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. - Abstract - Europe PMC
Long noncoding RNA and mRNA profiling in cetuximab‐resistant colorectal cancer cells by RNA sequencing analysis - Jing - 2019 - Cancer Medicine - Wiley Online Library
In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin Akbarzadeh-Sharbaf S, Yakhchali B, Minuchehr Z, Shokrgozar MA, Zeinali S - Adv Biomed Res
PRSS contributes to cetuximab resistance in colorectal cancer | Science Advances
Part:BBa K1694004 - parts.igem.org
AAVrh.10-mediated expression of cetuximab. A. Design of the... | Download Scientific Diagram
Frontiers | The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab via Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies
Schematic representation IdeS enzymatic cleavage of cetuximab.... | Download Scientific Diagram
